34 Quotes by Paul Nolte

We still like the fact that we're in an environment where no matter what happens in the economy, they (pharmaceutical companies) are still going to be doing business.

What a difference a week makes, from improprieties in the Japanese markets to still-higher oil prices amid diplomatic rumblings in the Middle East to less than stellar earnings.

We're getting a moderation in bond yields, and energy prices came down today. We're looking at things more favorably than this morning. There's still residual analysis about the Federal Reserve, and we're seeing some gamesmanship heading into next week's meeting, debating how more hikes we have.

We're still seeing reasonable growth in the economy ... and investors are figuring this is going to translate into strength in earnings.

We're still absorbing a lot of things. The risks right now are certainly still with the bond market. It's providing some good competition for stocks.

We ran out of gas after yesterday's large advance. We only had earnings news from a couple companies today, and that couldn't carry us.

I don't expect to see a sharp movement in stocks -- it will be a gradual erosion over time.

But that's more of a short-term phenomenon than anything worth paying a lot of attention to, ... it's going to come down to better economic numbers.

We may have broken out of our trading range, but we would like to see some follow-through before we commit additional dollars to the market.